Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

FHS
July 23, 2024
9:04 am

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

Beyond the gut: Crohn’s disease’s oral clues for timely diagnosis

The oral manifestations of CD.

October 12, 2023

Sanofi resolves most Zantac litigation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! Meghana here. Today,

April 5, 2024

As foundation for ‘excited delirium’ diagnosis cracks, fallout spreads

When Angelo Quinto’s family learned that officials blamed his 2020 death on “excited delirium,” a term they had never heard before, they couldn’t believe it.

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.